Pirfenidone for idiopathic pulmonary fibrosis

被引：66

作者：

Bouros, Demosthenes ^{[1
]}

机构：

[1] Democritus Univ Thrace, Sch Med, Dept Pneumonol, Alexandroupolis 68100, Greece

来源：

LANCET | 2011年 / 377卷 / 9779期

关键词：

D O I：

10.1016/S0140-6736(11)60546-1

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

引用

页码：1727 / 1729

页数：3

共 12 条

[1] Current and future therapeutic approaches in idiopathic pulmonary fibrosis [J].

Bouros, D ;

Antoniou, KM .

EUROPEAN RESPIRATORY JOURNAL, 2005, 26 (04) :693-702

[2] Interferon gamma for idiopathic pulmonary fibrosis [J].

Bouros, Demosthenes .

LANCET, 2009, 374 (9685) :180-182

[3] Idiopathic pulmonary fibrosis and pirfenidone [J].

Collard, H. R. .

EUROPEAN RESPIRATORY JOURNAL, 2010, 35 (04) :728-729

[4]

du Bois RM, 2011, AM J RESP CRIT CARE, V183, P1231, DOI [10.1164/rccm.201007-1179OC, 10.1164/rccm.201007.1179OC]

[5] Epidemiology of interstitial lung diseases in Greece [J].

Karakatsani, A. ;

Papakosta, D. ;

Rapti, A. ;

Antoniou, K. M. ;

Dimadi, M. ;

Markopoulou, A. ;

Latsi, P. ;

Polychronopoulos, V. ;

Birba, G. ;

Ch, Labrakis ;

Bouros, D. .

RESPIRATORY MEDICINE, 2009, 103 (08) :1122-1129

[6] Fibrotic idiopathic interstitial pneumonia - The prognostic value of longitudinal functional trends [J].

Latsi, PI ;

du Bois, RM ;

Nicholson, AG ;

Colby, TV ;

Bisirtzoglou, D ;

Nikolakopoulou, A ;

Veeraraghavan, S ;

Hansell, DM ;

Wells, AU .

AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2003, 168 (05) :531-537

[7] The clinical course of patients with idiopathic pulmonary fibrosis [J].

Martinez, FJ ;

Safrin, S ;

Weycker, D ;

Starko, KM ;

Bradford, WZ ;

King, TE ;

Flaherty, KR ;

Schwartz, DA ;

Noble, PW ;

Raghu, G ;

Brown, KK .

ANNALS OF INTERNAL MEDICINE, 2005, 142 (12) :963-967

[8] Pirfenidone in patients with idiopathic pulmonary fibrosis (CAPACITY): two randomised trials [J].

Noble, Paul W. ;

Albera, Carlo ;

Bradford, Williamson Z. ;

Costabel, Ulrich ;

Glassberg, Marilyn K. ;

Kardatzke, David ;

King, Talmadge E., Jr. ;

Lancaster, Lisa ;

Sahn, Steven A. ;

Szwarcberg, Javier ;

Valeyre, Dominique ;

du Bois, Roland M. .

LANCET, 2011, 377 (9779) :1760-1769

[9] Treatment of idiopathic pulmonary fibrosis with a new antifibrotic agent, pirfenidone - Results of a prospective, open-label phase II study [J].

Raghu, G ;

Johnson, WC ;

Lockhart, D ;

Mageto, Y .

AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 1999, 159 (04) :1061-1069

[10] An Official ATS/ERSARS/ALAT Statement: Idiopathic Pulmonary Fibrosis: Evidence-based Guidelines for Diagnosis and Management [J].

Raghu, Ganesh ;

Collard, Harold R. ;

Egan, Jim J. ;

Martinez, Fernando J. ;

Behr, Juergen ;

Brown, Kevin K. ;

Colby, Thomas V. ;

Cordier, Jean-Francois ;

Flaherty, Kevin R. ;

Lasky, Joseph A. ;

Lynch, David A. ;

Ryu, Jay H. ;

Swigris, Jeffrey J. ;

Wells, Athol U. ;

Ancochea, Julio ;

Bouros, Demosthenes ;

Carvalho, Carlos ;

Costabel, Ulrich ;

Ebina, Masahito ;

Hansell, David M. ;

Johkoh, Takeshi ;

Kim, Dong Soon ;

King, Talmadge E., Jr. ;

Kondoh, Yasuhiro ;

Myers, Jeffrey ;

Mueller, Nestor L. ;

Nicholson, Andrew G. ;

Richeldi, Luca ;

Selman, Moises ;

Dudden, Rosalind F. ;

Griss, Barbara S. ;

Protzko, Shandra L. ;

Schuenemann, Holger J. .

AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2011, 183 (06) :788-824

← 1 2 →